OYSTER POINT PHARMA INC (OYST) Stock Cash Flow
USA - NASDAQ:OYST - US69242L1061 - Common Stock
11.17 USD
+0.02 (+0.18%)
11.17 USD
0 (0%)
| TTM (2022-9-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -176.65M | -100.66M | -70.52M | -45.71M | -16.50M | |||
| Depreciation Amortization | 311.00K | 141.00K | 80.00K | 20.00K | N/A | |||
| Change In Working Capital | -15.72M | -2.49M | 5.07M | 1.61M | -730.00K | |||
| Interest Paid | N/A | 2.35M | N/A | N/A | N/A | |||
| Other non cash items | 26.07M | 13.64M | 6.97M | 3.27M | 150.00K | |||
| OPERATING CASH FLOW | -165.98M | -89.37M | -58.40M | -40.82M | -17.08M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -438.00K | -1.49M | -700.00K | -200.00K | 0.00 | |||
| INVESTING CASH FLOW | -438.00K | -1.49M | -700.00K | -200.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 96.60M | 96.59M | 112.91M | 174.99M | 0.00 | |||
| Other Financing Activity | -5.00M | -4.95M | -360.00K | N/A | 0.00 | |||
| FINANCING CASH FLOW | 50.99M | 91.64M | 112.55M | 174.99M | 0.00 | |||
| CHANGE IN CASH | -115.43M | 787.00K | 53.45M | 133.97M | -17.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -165.98M | -89.37M | -58.40M | -40.82M | -17.08M | |||
| Capital Expenditure | -438.00K | -1.49M | -700.00K | -200.00K | 0.00 | |||
| FREE CASH FLOW | -166.42M | -90.86M | -59.10M | -41.02M | -17.08M | |||
All data in USD